Abstract: Pityriasis amiantacea was first described in 1832. The disease may be secondary to any skin condition that primarily affects the scalp, including seborrheic dermatitis. Its pathogenesis remains uncertain. We aim to analyze the epidemiological and clinical profiles of patients with pityriasis amiantacea to better understand treatment responses. We identified seven cases of pityriasis amiantacea and a female predominance in a sample of 63 pediatric patients with seborrheic dermatitis followed for an average of 20.4 months. We reported a mean age of 5.9 years. Five patients were female, with a mean age of 9 years. All patients were successfully treated with topic ketoconazole.
1
Universidade Federal do Rio de Janeiro (UFRJ) -Rio de Janeiro (RJ), Brazil.
©2016 by Anais Brasileiros de Dermatologia
Pityriasis amiantacea (PA) can be described as an exaggerated inflammatory response pattern that affects the scalp, secondary to any dermatitis that may affect that region. It was first described by Alibert in 1832 as a condition characterized by thick silvery or yellowish scales, resembling asbestos fibers, strongly adhered to tufts of hair. 1 Frequency data for the disease are scarce in the literature and its etiopathogenesis remains unclear. Patients possibly present some sort of genetic or environmental predisposition for the disease. 1,2 Among the possible causes, we underline atopic and seborrheic dermatitis, psoriasis, and tinea capitis. However, it is known that the disease presents no associated dermatitis in certain cases. Table 1) . Among these patients, five were female (5/7, 71.4%) with a mean age at diagnosis of nine years (SD:
2.8 years). Clinically, all cases were associated with pruritus and erythema. Only one case showed scarring alopecia (1/7, 14.2%). Direct mycological examination and culture of scales and hair were negative. We opted for ketoconazole 2% shampoo, which is associated with topical mineral oil for removal of scales, as treatment for all pityriasis amiantacea patients. The average treatment time with daily application was 6.4 months (SD = 2.6 months). We also administered topical high-potency steroids (betamethasone dipropionate 0.1% solution) to 2 patients (28.4%). All seven patients responded fully to the treatment, with a mean follow-up of 9.8 months (SD = 8.2 months) ( Table 2 ).
Some authors suggest that pityriasis amiantacea is a possible complication in infants with seborrheic dermatitis. 5 Others are emphatic in pointing out that the reaction is more common among children although it can occur at any age. 6 The prospective study of 85 PA cases revealed a mean age diagnosis of 23.8 years in the interval ranging from 5 to 63 -thus encompassing children and adolescents, with a female predominance. In the present study, psoriasis accounted for 35.3% of the cases; aggregated seborrheic dermatitis and atopic eczema for 34.2%; tinea capitis -diagnosed by mycological examination -for 12.9% of cases. 2 Our research revealed that 11.1% of seborrheic dermatitis patients had pityriasis amiantacea during follow-up. Unlike the 42% described in the literature, 5 all 63 patients presented with scalp involvement in our study. In relation to diagnostic investigation, a scalp biopsy was probably not performed because histopathology is not presented as a fundamental 
* Standard deviation (SD).

